MX9703304A - Procedimiento de seleccion de una sal para preparar un complejo de inclusion. - Google Patents
Procedimiento de seleccion de una sal para preparar un complejo de inclusion.Info
- Publication number
- MX9703304A MX9703304A MX9703304A MX9703304A MX9703304A MX 9703304 A MX9703304 A MX 9703304A MX 9703304 A MX9703304 A MX 9703304A MX 9703304 A MX9703304 A MX 9703304A MX 9703304 A MX9703304 A MX 9703304A
- Authority
- MX
- Mexico
- Prior art keywords
- salt
- selecting
- making
- inclusion complex
- solubility
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Seasonings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un procedimiento para localizar una o más sales de un compuesto, teniendo dichas sales una solubilidad de una ciclodextrina igual o superior a una solubilidad objetivo de una ciclodextrina igual o superior a una solubilidad objetivo deseada, que incluye la obtencion de una serie de sales de dicho compuesto, medir la solubilidad en el equilibrio de cada sal de dicha serie en el ciclodextrina citada y comparar cada solubilidad medida con dicha solubilidad objetivo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1686696P | 1996-05-07 | 1996-05-07 | |
| US60/016,866 | 1996-05-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9703304A true MX9703304A (es) | 1998-05-31 |
| MXPA97003304A MXPA97003304A (es) | 1998-10-23 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| JPH1059871A (ja) | 1998-03-03 |
| CA2204451A1 (en) | 1997-11-07 |
| JP2000086539A (ja) | 2000-03-28 |
| EP0811386A2 (en) | 1997-12-10 |
| US20010007862A1 (en) | 2001-07-12 |
| DE69730902T2 (de) | 2006-02-23 |
| JP3007312B2 (ja) | 2000-02-07 |
| ES2224205T3 (es) | 2005-03-01 |
| DK0811386T3 (da) | 2005-01-03 |
| EP0811386B1 (en) | 2004-09-29 |
| ATE277641T1 (de) | 2004-10-15 |
| PT811386E (pt) | 2004-12-31 |
| CA2204451C (en) | 2004-06-29 |
| DE69730902D1 (de) | 2004-11-04 |
| EP0811386A3 (en) | 1999-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2204451A1 (en) | Method of selecting a salt for making an inclusion complex | |
| MY122167A (en) | Method for charactering subsurface petrophysical properties using linear shape attributes | |
| FI933702A (fi) | Menetelmä suhteellisen kosteuden mittaamiseksi, etenkin radiosondeissa | |
| IT1271687B (it) | Sali organici idrosolubili della creatina | |
| GB2363456A (en) | Seismic data acquisition method and apparatus | |
| MY110059A (en) | Method for determining borehole direction | |
| DE69112184D1 (de) | Eichung für zweikanalige Strahlungsmessung. | |
| DE69218400D1 (de) | Behälter für tiefgekühlten teig | |
| EP1033556A4 (en) | THREE-DIMENSIONAL MEASUREMENT METHOD AND STUDY INSTRUMENT USING THE SAME | |
| EP1571414A3 (en) | Apparatus and method for surface contour measurement | |
| DE59601350D1 (de) | Fmcw-abstandsmessverfahren | |
| DE3851951D1 (de) | Amperometrische Messmethode Amperometrische Messmethode. | |
| DE69432366D1 (de) | Kryochirurgische Sonde | |
| BR9607193B1 (pt) | teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos. | |
| AU4432096A (en) | Surveying and marking device | |
| DE69003090D1 (de) | Kalibrierungsverfahren eines dreidimensionalen formerfassungssystems und system zur durchführung des genannten verfahrens. | |
| FR2784137B1 (fr) | Procede permettant de corriger la caracteristique d'une sonde lambda lineaire | |
| DE69411499T2 (de) | Biologisch abbaubare Korrosionsinhibitoren mit niedriger Toxizität | |
| FI934267A0 (fi) | Menetelmä ja järjestely kosteuden mittauksessa, etenkin radiosondeissa | |
| DE69412118D1 (de) | Härteprüfung von stahl | |
| PA8477601A1 (es) | Inhibidores de las fkbp | |
| DE59203859D1 (de) | Verfahren zur kompensation quasiperiodischer störungen in messignalen. | |
| FI101176B1 (fi) | Mittauslaite ja menetelmä kohteiden mittaamiseksi | |
| SE9600623D0 (sv) | Automation methodology for 3 D image metrology systems | |
| SE9902141D0 (sv) | A method at a radar system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |